Governance Dottikon ES Holding AG

DESN

CH0582581713

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:20 2025-06-13 am EDT			5-day change	1st Jan Change
287.00 ^CHF	-1.03%		+4.55%	+29.86%

May. 28	Swiss Market Index Retreats; Dottikon ES Shares Soar	MT
May. 28	Swiss Chemicals Group Dottikon Surges 16% as Fiscal 2025 Profit Jumps Amid Capacity Boost	MT

Executive Committee: Dottikon ES Holding AG

Manager

Positions heldSince

Markus Blocher

54 year

Chief Executive Officer

2002-12-31

Marlene Born

50 year

Director of Finance/CFO	2005-12-31
Investor Relations Contact	2004-12-31

Karin Krause

57 year

Human Resources Officer

2014-12-31

Urs Brändli

65 year

Chief Tech/Sci/R&D Officer

2002-12-31

Composition of the Board of Directors: Dottikon ES Holding AG

Director

CommitteesSince

Markus Blocher

54 year

Compensation Committee

2011-12-31

Bernhard Urwyler

67 year

Compensation Committee

2020-07-02

Alfred Scheidegger

68 year

Compensation Committee

2011-06-30

Latest Appointments: Dottikon ES Holding AG

DOTTIKON ES Group Appoints Thomas Rosatzin as Member of the Senior Management and Head of Purchasing on April 1, 2014

14-02-05

More news

Former Officers and Directors: Dottikon ES Holding AG

Insider

Positions held

SinceUntil

Emanuel Tschannen

Human Resources Officer	2010-05-16	2015-05-31
General Counsel	2010-05-16	2015-05-31

Peter Grogg

Director/Board Member

2010-03-03

2012-07-05

Heinz Boller

Chairman

2010-05-16

2012-07-05

Thomas Früh

Director/Board Member

2012-07-05

Robert Hofer

Director/Board Member

2010-05-16

2010-07-01

Max Bachmann

Chief Tech/Sci/R&D Officer

1998-12-31

Kim Quach

Corporate Officer/Principal

2010-05-16

Brian Treco

Corporate Officer/Principal

2010-05-16

Brian Hausner

Corporate Officer/Principal

2010-05-16

Age distribution of managers

Parity Men Women

Male	5
Female	2

Of which Executive Committee

Male	2
Female	2

Of which Directors

Male	3
Female	0

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

ESG

ESG: Environment

ESG: Social

ESG: Governance

ESG: Controversy

ESG: Ethical controversies

ESG: Human rights controversies

ESG: Tax subsidies controversies

ESG: Sharia compliant

Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.

Employees

793

Sector

Pharmaceuticals

Calendar

Jul. 03 - Annual General Meeting

More about the company